Nausea Relief Chews Market: Crafting Comfortable Experiences

Posted 2024-05-08 19:24:51

111

According to a recently released Fact.MR analysis, the Nausea Relief Chews Market is expected to generate US$ 334 million in revenue in 2022 and is predicted to increase at a CAGR of 7.2% from 2023 to 2033. It is anticipated that the market will be valued US$ 712.9 million by the end of 2033. With a predicted 7% compound annual growth rate (CAGR) from 2023 to 2033, nausea relief chews for gastroesophageal reflux illness are expected to be the major revenue-generating segment.

Growing rates of nausea and vomiting, ease of consumption, a growing consumer preference for natural and herbal products, and rising public knowledge of the advantages of preventative healthcare are the main factors driving this market expansion.

Get Free Sample Copy of This Report:

https://www.factmr.com/connectus/sample?flag=S&rep_id=8792

The global antiemetic drug market was valued at US$ 2.5 billion in 2019 which increased to over US$ 3.8 billion in 2020, and is expected to grow at a CAGR of 5.7% during the forecast period. Many consumers prefer natural and herbal remedies over traditional medications due to concerns about side effects and long-term health consequences. Nausea relief chews made from natural ingredients are expected to be in high demand. Increasing prevalence of chronic diseases and a growing awareness of the use of natural and herbal products is expected to drive the market growth.

According to the International Agency for Research on Cancer (IARC), in 2020, around 19.3 million new cases of cancer were diagnosed worldwide, with 10.0 million cancer deaths. Lung cancer is the most common cancer in both men and women, accounting for approximately 11.6% of all new cancer cases. Breast cancer is the most commonly diagnosed cancer in women, accounting for 24.5% of all new cases. Nausea relief chews can provide several benefits for cancer patients who experience nausea and vomiting due to chemotherapy or radiation therapy. Thus, nausea relief chews is expected to witness an increase in sales due to growing prevalence of cancer during the forecast period.

Competitive Analysis:

Key players in the market are:-

Prestige Consumer Healthcare Inc.,
Megafood,
Webber Naturals,
Merck,
Sanofi,
Nauzene,
Pepto Bismol,
Ginger People,
Emetrol Chewables,
Cipla.

Get Customization on this Report for Specific Research Solutions:
https://www.factmr.com/connectus/sample?flag=RC&rep_id=8792

A few of the recent developments in the Nausea Relief Chews Market are:

In April 2021, Reckitt Benckiser Group plc (RB) announced the launch of its new product, Nauzene Kids Nausea Relief Chewables, which are designed specifically for children. The product is formulated with a combination of natural ingredients, including ginger and chamomile, and is intended to provide fast and effective relief from nausea, vomiting, and upset stomach.
In February 2021, Meijer Inc. announced the launch of its new product, Meijer Nausea Relief Chews, which are designed to provide fast and effective relief from nausea and upset stomach. The product is formulated with a combination of ginger and chamomile, and is available in a chewable tablet forms.

Segmentation of the Nausea Relief Chews Market:

By Indication:

Gastroesophageal Reflux Disease
Motion Sickness and Seasickness

By Distribution Channel:

Online Sales
Supermarkets/Hypermarkets
Hospital Pharmacies

By Region:

North America
Latin America
Europe
Asia Pacific
Middle East & Africa

Browse Full Report @ https://www.factmr.com/report/nausea-relief-chews-market

More Insights Available:

Fact.MR, in its new offering, presents an unbiased analysis of the Nausea Relief Chews Market, presenting historical market data (2018-2022) and forecast statistics for the period from 2023 to 2033.

The study reveals extensive growth in Nausea Relief Chews Market by Indication (Gastroesophageal Reflux Disease, Motion Sickness and Seasickness), by Distribution Channels (Online Sales, Supermarkets/Hypermarkets, Hospital Pharmacies) by Region (North America, Latin America, Europe, Asia- Pacific, Middle East and Africa) - 2023 to 2033.